Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Primary Sclerosing Cholangitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Minnesota, Minneapolis, Minnesota, United States
Contact: Study coordinator (Amanda Kabage) · kabage@umn.edu

Study leads

Elizabeth Aby
Principal Investigator
University of Minnesota

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

Primary Sclerosing Cholangitis · Biliary Atresia

Abroad (travel likely)RecruitingPHASE1

Sacramento, United States

Vancomycin in Primary Sclerosing Cholangitis in Italy

Primary Sclerosing Cholangitis · Liver and Intrahepatic Bile Duct Disorder · IBD

Abroad (travel likely)RecruitingPHASE2

Monza, Italy

A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

Healthy Volunteers · Primary Sclerosing Cholangitis

Abroad (travel likely)RecruitingPHASE1

Salt Lake City, United States

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study

Primary Sclerosing Cholangitis · Inflammatory Bowel Diseases

Abroad (travel likely)RecruitingEARLY_PHASE1

Stanford, United States